Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 08, 2024 09:30 ET | Source: Future Market Insights Global and Consulting Pvt. Ltd.

Tissue Engineered Skin Substitute Market Projected to Reach US$ 3.5 Billion by 2034 | Future Market Insights, Inc.

NEWARK, Del, April 08, 2024 (GLOBE NEWSWIRE) -- The tissue engineered skin substitute market is expected to reach a value of US$ 2.4 billion in 2024, with projections indicating a growth to US$ 3.5...
March 23, 2023 07:30 ET | Source: BioStem Technologies, Inc.

BioStem Technologies Commends OIG's Recommendation for CMS to Address ASP Reporting Requirements for Skin Substitute Products

POMPANO BEACH, FLORIDA., March 23, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies (“BioStem” or the “Company”) (OTCQB: BSEM), a leading provider of innovative regenerative medicine solutions, is...
April 29, 2019 08:00 ET | Source: Medovex Corp.

Medovex Corporation Announces Recent Management Appointments

ALPHARETTA, Ga., April 29, 2019 (GLOBE NEWSWIRE) -- Medovex Corporation (OTCQB: MDVX) (“Medovex” or the “Company”), the owner and operator of innovative medical technology products and services...
April 08, 2019 08:50 ET | Source: Medovex Corp.

Medovex Corporation Closes Financing for a Total $7.2M Under Existing Securities Purchase Agreement

ALPHARETTA, Ga., April 08, 2019 (GLOBE NEWSWIRE) -- Medovex Corporation (OTCQB: MDVX) (“Medovex” or the “Company”) today announced that on April 1, 2019, the Company entered into a securities...
February 04, 2019 08:00 ET | Source: Medovex Corp.

Medovex Corporation Announces Name Change and Full Rebranding to Blue Zone Health

ALPHARETTA, Ga., Feb. 04, 2019 (GLOBE NEWSWIRE) -- Medovex Corporation (OTCQB: MDVX) (“Medovex” or the “Company”) today announced it is now Blue Zone Health. The announcement signals the company's...
January 28, 2019 08:00 ET | Source: Medovex Corp.

Medovex Corporation Receives an Additional $2.9 Million Under Existing Securities Purchase Agreement

ALPHARETTA, Ga., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Medovex Corporation (OTCQB: MDVX) (“Medovex” or the “Company”) today announced that on January 18, 2019, the Company entered into a securities...
January 15, 2019 08:30 ET | Source: Medovex Corp.

Medovex Corporation Announces New Board Appointments

ALPHARETTA, Ga., Jan. 15, 2019 (GLOBE NEWSWIRE) -- Medovex Corporation (OTCQB: MDVX) (“Medovex” or the “Company”) today named Michael Yurkowsky, founder of YP Holdings, and Raymond Monteleone,...
January 14, 2019 08:00 ET | Source: Medovex Corp.

Medovex Corporation Closes Acquisition of Pulmonary Biomedical Services and Patient Delivery Platform of Regenerative Medicine Solutions, LLC

ALPHARETTA, Ga., Jan. 14, 2019 (GLOBE NEWSWIRE) -- Medovex Corporation (OTCQB: MDVX) (“Medovex” or the “Company”) today announced that it has closed the acquisition of substantially all of the...
October 16, 2018 08:00 ET | Source: Medovex Corp.

Medovex Corporation Announces Definitive Agreement to Acquire the Pulmonary Biomedical Services and Patient Delivery Platform of Regenerative Medicine Solutions, LLC

ALPHARETTA, Ga., Oct. 16, 2018 (GLOBE NEWSWIRE) -- Medovex Corporation (OTCQB: MDVX) (“Medovex”) announced today that it has signed a definitive agreement to acquire the pulmonary biomedical...